Adma Biologics reported $300.56M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US USD 10.93M 1.21M
Adma Biologics ADMA:US USD 300.56M 3.63M
Agile Therapeutics AGRX:US USD 14.24M 4.22M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Dynavax Technologies DVAX:US USD 985.85M 13.49M
Minerva Neurosciences NERV:US USD 55.09M 4.67M
Novavax NVAX:US USD 2.26B 8.76M
Omeros OMER:US USD 590.97M 133.42M
Takeda 4502:JP JPY 13.5T 1.08T